Cargando…
DNA hypermethylation of the ZNF132 gene participates in the clinicopathological aggressiveness of ‘pan-negative’-type lung adenocarcinomas
Although some previous studies have examined epigenomic alterations in lung adenocarcinomas, correlations between epigenomic events and genomic driver mutations have not been fully elucidated. Single-CpG resolution genome-wide DNA methylation analysis with the Infinium HumanMethylation27 BeadChip wa...
Autores principales: | Hamada, Kenichi, Tian, Ying, Fujimoto, Mao, Takahashi, Yoriko, Kohno, Takashi, Tsuta, Koji, Watanabe, Shun-ichi, Yoshida, Teruhiko, Asamura, Hisao, Kanai, Yae, Arai, Eri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905838/ https://www.ncbi.nlm.nih.gov/pubmed/33152763 http://dx.doi.org/10.1093/carcin/bgaa115 |
Ejemplares similares
-
Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas: significance of cell adhesion and epithelial–mesenchymal transition-related signaling pathways
por: Yang, Menghan, et al.
Publicado: (2020) -
Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas
por: Arai, Eri, et al.
Publicado: (2015) -
Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling
por: Endo, Yutaka, et al.
Publicado: (2021) -
Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification
por: Liu, Zhao, et al.
Publicado: (2021) -
Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas
por: Arai, Eri, et al.
Publicado: (2012)